News
Important Only
Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
June 23 (Reuters) - Carisma Therapeutics Inc CARM.O:CARISMA THERAPEUTICS AND ORTHOCELLIX ENTER INTO DEFINITIVE MERGER AGREEMENT TO CREATE COMPANY FOCUSED ON REGENERATIVE CELL THERAPIES FOR ORTHOPEDIC DISEASESCARISMA THERAPEUTICS INC - ORTHOCELLIX TO MERGE INTO WHOLLY-OWNED SUBSIDIARY OF CARISMACARIS...Reuters
Mon, Jun 23
UK's CMA Considers If Getty Images-Shutterstock Merger Will Result In Relevant Merger Situation
June 23 (Reuters) - UK's CMA:COMPETITION AND MKTS - MERGER UPDATE : GETTY IMAGES / SHUTTERSTOCKUK'S CMA: INVITATION TO COMMENT CLOSES 7 JULY 2025 FOR GETTY IMAGES / SHUTTERSTOCK MERGERUK'S CMA: CONSIDERING WHETHER GETTY IMAGES / SHUTTERSTOCK MERGER WILL RESULT IN CREATION OF A RELEVAN...Reuters
Mon, Jun 23
China says Taiwan president spreading 'heresy' with sovereignty speech
BEIJING, June 23 (Reuters) - China on Monday accused Taiwanese President Lai Ching-te of "heresy", hostility and provocation, after a speech in which he said the island is "of course" a country and there is historical evidence and legal proof to back this up.Beijing says democratical...Reuters
Mon, Jun 23
Palvella Therapeutics Completes Enrollment In Phase 3 Selva Trial Of Qtorin™ Rapamycin For Microcystic Lymphatic Malformations, Exceeding Enrollment Target By Over 25%
June 23 (Reuters) - Palvella Therapeutics Inc PVLA.O:PALVELLA THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 3 SELVA TRIAL OF QTORIN™ RAPAMYCIN FOR MICROCYSTIC LYMPHATIC MALFORMATIONS, EXCEEDING ENROLLMENT TARGET BY OVER 25%PALVELLA THERAPEUTICS INC - TOP-LINE DATA EXPECTED IN Q1 2026Reuters
Mon, Jun 23
Novo Nordisk Terminates Collaboration With Hims & Hers Health
June 23 (Reuters) - Novo Nordisk A/S NOVOb.CO:TERMINATES COLLABORATION WITH HIMS & HERS HEALTH, INCDIRECT ACCESS TO WEGOVY® WILL NO LONGER BE AVAILABLE TO HIMS & HERS HEALTH, INC. VIA NOVOCARE® PHARMACYFurther company coverage: [NOVOb.CO]Reuters
Mon, Jun 23
ADVISORY-Alert wrongly tagged to Natural Gas Services Group withdrawn
An alert on IT services and consulting firm ePlus Inc PLUS.O entering an agreement to sell its financing business to PEAC was incorrectly tagged to natural gas and oil firm Natural Gas Services Group NGS.N, an unrelated company, and has been withdrawn.For the correctly tagged alerts on ePlus, click ...Reuters
Mon, Jun 23
Walmart-backed PhonePe prepares for $1.5 billion India IPO, Bloomberg News reports
June 23 (Reuters) - Walmart WMT.N-backed Indian fintech firm PhonePe is preparing to file preliminary documents for its initial public offering to raise as much as $1.5 billion, Bloomberg News reported on Monday, citing people familiar with the matter. The IPO would value PhonePe at nearly $15 billi...Reuters
Mon, Jun 23
Health insurers to work on easing prior authorization requirements, AHIP says
June 23 (Reuters) - America's Health Insurance Plans said on Monday that U.S. health insurers will take additional measures to simplify their requirements for prior approval on medicines and medical services. Health insurers will work to develop standardized data and submission requiremen...Reuters
Mon, Jun 23
Forte Biosciences Announces Positive Data In Fb102 Celiac Disease Phase 1B Study
June 23 (Reuters) - Forte Biosciences Inc FBRX.O:FORTE BIOSCIENCES ANNOUNCES POSITIVE DATA IN FB102 CELIAC DISEASE PHASE 1B STUDYFORTE BIOSCIENCES INC - FB102 SHOWS SIGNIFICANT BENEFIT ON VCIEL ENDPOINTFORTE BIOSCIENCES INC - FB102 SHOWS DECLINE IN CD3-POSITIVE T CELLS DENSITYReuters
Mon, Jun 23
Illumina To Acquire Somalogic, Accelerating Its Proteomics Business
June 23 (Reuters) - Illumina Inc ILMN.O:ILLUMINA TO ACQUIRE SOMALOGIC, ACCELERATING ITS PROTEOMICS BUSINESS AND ADVANCING THE COMPANY'S MULTIOMICS STRATEGYILLUMINA INC - TO BUY SOMALOGIC FOR $350 MILLION PLUS $75 MILLION IN MILESTONESILLUMINA INC - EXPECTS SOMALOGIC BUSINESS TO BE PROFITABLE IN ...Reuters
Mon, Jun 23
